It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2017.
2017 | Mumbai, Maharashtra, India | ActiveAlmark Pharma Private Limited, a active private limited company, was established on 11 January 2017 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U36999MH2017PTC289446. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Saad Abdul Sattar Memon (Director), Nabeel Ahmed Khan (Director). Past directors included Mohammed Saad Ismail Patel, Raheel Jameel Ahmed Khan, Rahemtulla Kasamali Prasla. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B/004, Raj Nagar Coop Housing Society Ltd, Sv Road, Opp Ram Shyam, Jogeshwari West,, Mumbai, Maharashtra, 400102.
U36999MH2017PTC289446
289446
11 January 2017
₹1.00 M
₹1.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Almark Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Saad Abdul Sattar Memon | Director | 11 Jan 2017 | Current |
| Nabeel Ahmed Khan | Director | 11 Jan 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Dec 2024 | Past |
| Pramod Abcsdd | Director | 23 Dec 2024 | Past |
| Pramod Abcsdd | Director | 12 Oct 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Almark Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 31.87% increase in profit. The company's net worth dipped by a decrease of 3.13%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
In 2019, Almark Pharma had a promoter holding of 85.00% and a public holding of 15.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Almark Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Almark Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Almark Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Almark Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Almark Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Progress on Saad Abdul Sattar Memon was appointed as a Director was appointed as a Director on 11 Jan 2017 & has been associated with this company since 8 years 10 months . was documented.
Progress on Nabeel Ahmed Khan was appointed as a Director was appointed as a Director on 11 Jan 2017 & has been associated with this company since 8 years 10 months . was documented.
Almark Pharma Private Limited was registered on 11 Jan 2017 with Roc Mumbai & aged 8 years 10 months as per MCA records. was recorded as a recent event.
The CIN of Almark Pharma Private Limited is U36999MH2017PTC289446.
Almark Pharma Private Limited is headquartered at B/004, Raj Nagar Coop Housing Society Ltd, Sv Road, Opp Ram Shyam, Jogeshwari West,, Mumbai, Maharashtra, 400102.
Almark Pharma Private Limited was incorporated on 11 January 2017.
The current directors of Almark Pharma Private Limited are
The primary industry of Almark Pharma Private Limited is Pharma.
Almark Pharma Private Limited is unlisted.
The authorized capital of Almark Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Almark Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX